Log in

1681 Consun Pharmaceutical Group Ltd. HKEX · China

Consun Pharmaceutical Group (1681) news

Consun Pharmaceutical Group Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1681, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Consun Pharmaceutical Group news

We have not published a story on Consun Pharmaceutical Group yet. When there is news, it will appear here.

Questions about Consun Pharmaceutical Group

What is the ticker symbol of Consun Pharmaceutical Group?

Consun Pharmaceutical Group Ltd. trades under the ticker 1681 on HKEX.

Where is Consun Pharmaceutical Group listed?

Consun Pharmaceutical Group Ltd. is listed on HKEX. Our directory also records these other listings: LS:A1XAEC; LSX:A1XAEC.

Which country or territory is Consun Pharmaceutical Group listed under?

Our directory records Consun Pharmaceutical Group Ltd. under China.

What does Consun Pharmaceutical Group do?

Our directory classifies Consun Pharmaceutical Group Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Consun Pharmaceutical Group?

The ISIN recorded for Consun Pharmaceutical Group Ltd. is KYG2524A1031.

Does aibio.space cover Consun Pharmaceutical Group?

aibio.space lists Consun Pharmaceutical Group Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Consun Pharmaceutical Group?

Companies in our directory listed in the same country and business area as Consun Pharmaceutical Group: China National Accord Medicines Corporation, Shandong Wohua Pharmaceutical Co., Shandong Boan Biotechnology Company., Limited., RemeGen Co., Wuhan YZY Biopharma Co., Hunan Fangsheng Pharmaceutical Co..

Investor discussion: Consun Pharmaceutical Group

Members talk about Consun Pharmaceutical Group (1681). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Consun Pharmaceutical Group, newest first. Each line links the filing it comes from.

  1. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS FOR WEALTH MANAGEMENT PRODUCTS. Source

Press releases

Headlines of Consun Pharmaceutical Group's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    Notification Letter to Non-Registered Shareholders and Reply Form

  2. HKEXnews

    Notification Letter to Registered Shareholders and Reply Form

  3. HKEXnews

    Interim Dividend for the six months ended 30 June 2026

  4. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  5. HKEXnews

    VOLUNTARY ANNOUNCEMENT ACQUISITION OF 30% EQUITY INTEREST IN SHANGHAI HUAMAO PHARMACEUTICAL CO., LTD.

  6. HKEXnews

    VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE PROGRAM UNDER THE REPURCHASE MANDATE

  7. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, 26 MAY 2026

  8. HKEXnews

    Notification Letter to Shareholders - Annual General Meeting

  9. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  10. HKEXnews

    Final Dividend for the year ended 31 December 2025

  11. HKEXnews

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025

  12. HKEXnews

    Terms of Reference of the Environmental, Social and Governance Committee of the Board of Directors

  13. HKEXnews

    THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

  14. HKEXnews

    POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON TUESDAY, 23 DECEMBER 2025

  15. HKEXnews

    2025 Share Award Scheme

  16. HKEXnews

    Notification Letter to Shareholders - Extraordinary General Meeting

  17. HKEXnews

    NOTICE OF EXTRAORDINARY GENERAL MEETING

  18. HKEXnews

    (1) PROPOSED ADOPTION OF THE SHARE AWARD SCHEME, (2) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND (3) NOTICE OF EGM

  19. HKEXnews

    BOOK CLOSURE PERIOD AND RECORD DATE

  20. HKEXnews

    PROPOSED ADOPTION OF SHARE AWARD SCHEME

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:1681 on TradingView.

Listing details

Consun Pharmaceutical Group Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1681, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Consun Pharmaceutical Group Ltd.
Ticker
1681
Listing
HKEX
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
KYG2524A1031
Other listed symbols
LS:A1XAEC; LSX:A1XAEC
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.